Fake Mounjaro Scam: Unapproved 'Toneup' Tirzepatide Shots Sold via IndiaMART Written By Susmita Roy29 April 2026 4:15 PM ISTNew Delhi: The case of counterfeit Mounjaro injections being produced from a Sector 62 flat reveals a deeply troubling lapse in drug regulation and...
Cough Syrup Death-Linked Pharma Firm Resurfaces Under New Name, Sparks Regulatory Concerns Written By Susmita Roy26 April 2026 10:15 AM ISTNew Delhi: Raising alarming concerns, a pharmaceutical firm previously associated with tragic child fatalities linked to contaminated cough syrup has...
Quadria Capital-Led Consortium Eyes Majority Stake in Samarth Lifesciences at Rs 4,500 Cr Valuation Written By Parthika Patel25 April 2026 5:40 PM ISTNew Delhi: A consortium of private equity investors, led by healthcare-focused Quadria Capital, is assessing the acquisition of an 80-85% stake in...
Aurobindo Pharma Gets USFDA Nod for Generic Ravicti to Treat Urea Cycle Disorders Written By Parthika Patel17 April 2026 4:37 PM ISTNew Delhi: Aurobindo Pharma Limited has received final approval from the United States Food and Drug Administration (USFDA) for Glycerol...
DCGI Pushes Reforms, Drug Approvals Now Within 150 Days Written By Susmita Roy16 April 2026 8:51 PM ISTNew Delhi: India's drug regulatory authority has significantly cut down approval timelines by more than 50% and simplified several key regulatory...
Rubicon Research Acquires 85% Stake in Arinna for Rs 176 Cr, Enters CNS Market Written By Parthika Patel16 April 2026 8:38 PM ISTNew Delhi: Rubicon Research Limited has acquired an 85% equity stake in Arinna Lifesciences Limited for approximately Rs 175.92 crore, valuing the...
Hetero Targets 1.5 Million Semaglutide Pens, Eyes 75+ Markets Written By sheeba farhat16 April 2026 8:30 PM ISTHyderabad: Hetero Labs, one of India's largest privately held drugmakers, aims to sell 1.5 ​million pens of generic weight-loss and diabetes drugs in...
Domestic Pharma Growth Strong, US Market Drag to Weigh on Q4FY26 Earnings: Report Written By sheeba farhat10 April 2026 9:01 PM ISTNew Delhi: India's pharmaceutical sector is likely to witness steady domestic growth but continued pressure in the US market in the fourth quarter of...
JB Chemicals Appoints Aman Mehta as MD, Expands Board with Three New Directors Written By Parthika Patel26 March 2026 11:47 PM ISTMumbai: J.B. Chemicals & Pharmaceuticals Limited has announced key changes to its board following shareholder approval via postal ballot,...
State Drug Alert: From Antibiotics to Antihypertensives, 134 Samples Found NSQ in February Audit Written By Susmita Roy25 March 2026 11:36 PM ISTNew Delhi: Reflecting ongoing concerns over drug quality in India, the Central Drugs Standard Control Organisation (CDSCO) has flagged 134 drug...
Wockhardt's Nafithromycin 400 mg May Get 5-Year Price Control Exemption Written By Susmita Roy8 March 2026 1:00 PM ISTNew Delhi: The National Pharmaceutical Pricing Authority (NPPA) Multidisciplinary Committee (MDC) has recommended granting exemption from price...
CDSCO Clears AstraZeneca's Imfinzi (Durvalumab) for Additional Cancer Indication in India Written By Farhat Nasim10 Feb 2026 8:10 PM ISTNew Delhi: AstraZeneca Pharma India Ltd on Tuesday said it has received permission from India's drug regulator to market Durvalumab solution for...
